Dec 19 2017

Who We Are #skye #pharma

#pharma technology


Who We Are

A revolutionary pharmaceutical platform technology with anti-viral, anti-bacterial, anti-fungal and anti-inflammatory properties

Fulhold Pharma plc produces the patented CarboHydrate Derived Fulvic Acid (CHD-FA) and formulations containing this product. CHD-FA and its use provides a new pharmaceutical platform technology with wide applications in human and animal health.

We produce CHD-FA using a sustainable, environmentally-friendly technology, the process of which is also patented.

Its powerful broad-spectrum activity makes CHD-FA an effective agent in the fight against infection, including drug-resistant forms. Given its novel mechanism of action, the use of CHD-FA is advantageous as it prevents the use (and therefore over-use) of more specific but more limited spectrum antibiotics.

Founded as Ful Hold Ltd in 2002, Fulhold Pharma plc has a proven track record of the production and supply of pure CHD-FA together with a range formulated products using CHD-FA as the platform technology.


Written by admin

Leave a Reply

Your email address will not be published. Required fields are marked *